01.05.2014 | Erratum
Erratum to: Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2014
Einloggen, um Zugang zu erhaltenExcerpt
An error occurred in the Methods section, which is corrected here. The first sentence in the second paragraph, under the heading “Neoadjuvant Chemotherapy Regimen,” should read:The sentence as originally published, “Eligible patients were started on an eight-cycle course of 1,000 mg/m2 of gemcitabine and 80 mg/m2 of docetaxel given on days 1 and 8, every 21 days, with intermittent restaging by computed tomographic scan and cancer antigen (CA) 19–9 levels,” is incorrect. …Eligible patients were started on an eight-cycle course of 1,000 mg/m2 of gemcitabine and 40 mg/m2 of docetaxel given on days 1 and 8, every 21 days, with intermittent restaging by computed tomographic scan and cancer antigen (CA) 19–9 levels.